Understanding the Impact of IBS in Australia: The Implications of Anatara Lifesciences’ GaRP-IBS Trial
In Australia, Irritable Bowel Syndrome (IBS) is a prevalent and impactful condition, affecting approximately 1 in 7 individuals and placing ...
Tag: GaRP IBS trial
Popular News
-
As Microsoft Exchange 2016 and 2019 Sunset, How Can Privacy-Conscious Organisations Future-Proof their Email?
-
Unmasking the ‘Fin-Fluencer’ Phenomenon: 80% of Forex Advice on TikTok Is Potentially Misleading
-
MyGov Not Working? Here’s How to Fix It Fast (2025 Guide)
-
10 Australian Strategy Consultants Leading Change in 2026
-
The 10 Australian Makeup Artists to Watch in 2021
